Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
104.70B
Market cap104.70B
Price-Earnings ratio
28.64
Price-Earnings ratio28.64
Dividend yield
1.26%
Dividend yield1.26%
Average volume
2.59M
Average volume2.59M
High today
$278.75
High today$278.75
Low today
$271.64
Low today$271.64
Open price
$272.00
Open price$272.00
Volume
1.57M
Volume1.57M
52 Week high
$395.90
52 Week high$395.90
52 Week low
$271.64
52 Week low$271.64

Stock Snapshot

The current Stryker(SYK) stock price is $272.95, with a market capitalization of 104.7B. The stock trades at a price-to-earnings (P/E) ratio of 28.64 and offers a dividend yield of 1.26%.

As of 2026-09-09, Stryker(SYK) stock has fluctuated between $271.64 and $278.75. The current price stands at $272.95, placing the stock +0.5% above today's low and -2.1% off the high.

Stryker(SYK) shares are trading with a volume of 1.57M, against a daily average of 2.59M.

In the last year, Stryker(SYK) shares hit a 52-week high of $395.90 and a 52-week low of $271.64.

In the last year, Stryker(SYK) shares hit a 52-week high of $395.90 and a 52-week low of $271.64.

SYK News

Investing.com 4h
Wells Fargo cuts Stryker stock price target on revenue concerns - Investing.com

...

Wells Fargo cuts Stryker stock price target on revenue concerns - Investing.com
TipRanks 4h
Stryker price target lowered to $348 from $418 at Wells Fargo

Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Stryker (SYK) to $348 from $418 and keeps an Overweight rating on the shares. The firm ho...

Seeking Alpha 24h
Stryker drops after comments on vascular and ortho segments

Stryker Corporation (SYK) hit a new 52-week low, sending shares of its rival Zimmer Biomet (ZBH) lower after discussing headwinds in its vascular and orthopedic...

Stryker drops after comments on vascular and ortho segments

Analyst ratings

80%

of 30 ratings
Buy
80%
Hold
20%
Sell
0%

More SYK News

24/7 Wall St. 5d
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money

Investing Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money Both Intuitive Surgical and Stryke...

Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
TipRanks 7d
Stryker Insider Makes Bold New Move With Fresh Share Purchase

New insider activity at Stryker ( (SYK) ) has taken place on September 2, 2026. Director Mary Brainerd has strengthened her stake in Stryker by purchasing 131...

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.